Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fisher, Bradford Hill, and randomization.

Literature DB >> 14681247

Fisher, Bradford Hill, and randomization.

Peter Armitage¹.

Abstract

Mesh：

Year: 2003 PMID： 14681247 DOI： 10.1093/ije/dyg286

Source DB: PubMed Journal: Int J Epidemiol ISSN： 0300-5771 Impact factor: 7.196

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.

Authors: Steffen Ventz; Albert Lai; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal: Clin Cancer Res Date: 2019-06-07 Impact factor: 12.531

2. To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs.

Authors: Alyssa M Vanderbeek; Steffen Ventz; Rifaquat Rahman; Geoffrey Fell; Timothy F Cloughesy; Patrick Y Wen; Lorenzo Trippa; Brian M Alexander
Journal: Neuro Oncol Date: 2019-10-09 Impact factor: 12.300

3. Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.

Authors: Stuart A Grossman; Karisa C Schreck; Karla Ballman; Brian Alexander
Journal: Neuro Oncol Date: 2017-04-01 Impact factor: 12.300

Fisher, Bradford Hill, and randomization.

1. Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data.

2. To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs.

3. Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.

4. Author's reply.

5. Major Greenwood and clinical trials.

6. The Bradford Hill considerations on causality: a counterfactual perspective.

7. Improved stratification of ALS clinical trials using predicted survival.

8. Survival analysis following dynamic randomization.

9. Training in clinical research in India: potential and challenges.

10. Rethinking bias and truth in evidence-based health care.